These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 2216952

  • 21. Spiking expression of mu-crystallin mRNA during treatment with methimazole in patients with graves' hyperthyroidism.
    Suzuki S, Takei M, Nishio S, Inaba H, Sato A, Yamazaki M, Shinomiya K, Hashizume K.
    Horm Metab Res; 2009 Jul; 41(7):548-53. PubMed ID: 19280551
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Evaluation of metabolic efficiency of the liver in patients with psoriasis by the antipyrine test].
    Bienias L, Czarnecki M, Kaszuba A, Ruszczak Z, Kozłowska M, Bednarowicz G, Drobnik G.
    Przegl Dermatol; 1990 Jul; 77(5):301-6. PubMed ID: 2270292
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC, Pei D, Wang TF, Wu DA, Li JC, Wei CL, Lee CH, Chen SP, Kuo SW.
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antithyroid drug-induced immunomodulation in Graves' disease patients.
    Lechpammer M, Lukac J, Lechpammer S, Kusić Z.
    Acta Med Croatica; 2002 May; 56(1):21-6. PubMed ID: 12455450
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Comparison of thiamazole pharmacokinetics in healthy individuals and patients with hyperthyroidism].
    Syrenicz A, Gawrońska-Szklarz B, Wójcicki J, Czekalski S.
    Pol Tyg Lek; 2002 May; 46(43-44):838-40. PubMed ID: 1669174
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [The assessment of liver microsomal oxidative capacity via caffeine and antipyrine elimination in patients with chronic active hepatitis: preliminary results].
    Soto Alvarez J, Alsar Ortiz MJ.
    An Med Interna; 1992 Nov; 9(11):547-50. PubMed ID: 1467403
    [Abstract] [Full Text] [Related]

  • 32. [Effect of mestranol on pharmacokinetics of phenazone in the rabbit].
    Gawrońska-Szklarz B, Droździk M, Kwiatkowski A, Wójcicki J.
    Ginekol Pol; 1996 Jan; 67(1):1-6. PubMed ID: 8655012
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of phenazone (antipyrine) in rabbits with experimental common bile duct obstruction.
    Wójcicki J, Sulikowski T, Wójcicki M, Droździk M, Gawrońska-Szklarz B, Barcew-Wiszniewska B, Skowron J, Rózewicka L.
    Br J Pharmacol; 1996 Jan; 117(1):1-4. PubMed ID: 8825335
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Michaëlis--Menten kinetics of phenazone elimination in the perfused pig liver.
    Andreasen B, Tonnesen K, Rabol A, Keiding S.
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):1-13. PubMed ID: 576352
    [Abstract] [Full Text] [Related]

  • 39. [Pharmacokinetics of phenazone after bilateral ovariectomy in female rabbits].
    Gawrońska-Szklarz B, Kwiatkowski A, Droździk M, Wójcicki J.
    Ginekol Pol; 1992 Feb; 63(2):57-61. PubMed ID: 1305588
    [Abstract] [Full Text] [Related]

  • 40. [Detoxification function of the liver and body resistance in patients with acute intestinal obstruction].
    Razzakov SM, Krakovskiĭ ME, Ashirmetov AKh.
    Khirurgiia (Mosk); 1990 Dec; (12):11-5. PubMed ID: 2079783
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.